Department of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
J Allergy Clin Immunol. 2012 Jun;129(6):1529-37.e2. doi: 10.1016/j.jaci.2012.01.051. Epub 2012 Mar 3.
Although evidence suggests that ambient exposures to endotoxin and other immunostimulants during early life influence allergic risk, efforts to understand this host-environment relationship have been hampered by a paucity of relevant assays.
These investigations determined whether parameters of house dust extract (HDE) bioactivity were predictive of allergen skin prick test (SPT) reactivity for infants at high risk of allergy participating in the Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS).
We conducted a nested case-control study, selecting 99 CCAAPS children who had positive SPT results to at least 1 aeroallergen at age 3 years and 101 subjects with negative SPT results. HDEs were prepared from dust samples collected from the subjects' homes at age 1 year. Murine splenocytes and bone marrow-derived dendritic cells were incubated with HDEs, and supernatant cytokine concentrations were determined by means of ELISA. Alternatively, bone marrow-derived dendritic cells were preincubated with HDEs, and then LPS-induced IL-6 responses were assessed. HDE endotoxin levels were determined by using the limulus amebocyte lysate assay.
HDEs derived from the homes of children with positive (cases) and negative (control subjects) SPT results had similar bioactivities. However, when cases were considered in isolation, HDEs with higher levels of bioactivity were significantly associated with children who had lower numbers of positive SPT results. Analogous statistical analyses did not identify any association between HDE endotoxin levels and the aeroallergen sensitization profiles of children included in this study.
HDE immunostimulatory activities predicted the aeroallergen sensitization status of CCAAPS subjects better than HDE endotoxin levels. These results provide the first published evidence that HDE bioassays have clinical relevance in predicting atopic risk.
尽管有证据表明,生命早期环境中内毒素和其他免疫刺激物的暴露会影响过敏风险,但由于缺乏相关检测方法,人们对这种宿主-环境关系的理解仍受到阻碍。
本研究旨在确定房屋灰尘提取物(HDE)生物活性的参数是否可预测参与辛辛那提儿童过敏和空气污染研究(CCAAPS)的高过敏风险婴儿的过敏原皮肤点刺试验(SPT)反应。
我们进行了一项巢式病例对照研究,选择了 99 名 CCAAPS 儿童,他们在 3 岁时对至少 1 种气传过敏原的 SPT 结果呈阳性,101 名儿童的 SPT 结果呈阴性。HDE 是从 1 岁时从研究对象家中采集的灰尘样本中制备的。用 HDE 孵育鼠脾细胞和骨髓来源的树突状细胞,通过 ELISA 测定上清细胞因子浓度。或者,先用 HDE 孵育骨髓来源的树突状细胞,然后评估 LPS 诱导的 IL-6 反应。用鲎变形细胞溶解物测定法测定 HDE 内毒素水平。
来自 SPT 阳性(病例)和阴性(对照)儿童家庭的 HDE 具有相似的生物活性。然而,当单独考虑病例时,生物活性较高的 HDE 与 SPT 阳性结果较少的儿童显著相关。类似的统计分析并未发现 HDE 内毒素水平与纳入本研究的儿童的气传过敏原致敏谱之间存在任何关联。
HDE 免疫刺激活性比 HDE 内毒素水平更能预测 CCAAPS 受试者的气传过敏原致敏状态。这些结果首次提供了 HDE 生物测定在预测特应性风险方面具有临床相关性的证据。